Patient Advocate Solutions LLC is categorized under Business Services (Unclassified) in Middlesex, NJ .
Patient Advocate Solutions LLC was established in 0, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Michael Chritian at the company’s single location by writing to 1275 Bound Brook Road, Middlesex, New Jersey NJ 08846 or by phoning (732) 564-9800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Patient Advocate Solutions LLC |
| Contact Person: | Michael Chritian |
| Address: | 1275 Bound Brook Road, Middlesex, New Jersey 08846 |
| Phone Number: | (732) 564-9800 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Patient Advocate Solutions LLC was started in 0 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Michael Chritian for inquiries that concern Patient Advocate Solutions LLC by calling the company number (732) 564-9800, as your correspondence is most welcome. Additionally, the physical location of the single location of Patient Advocate Solutions LLC can be found at the coordinates as well as the street address 1275 Bound Brook Road in Middlesex, New Jersey 08846.
For its online presence, you may visit Patient Advocate Solutions LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.